Cyrus Biotechnology

Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.

This Software-as-a-Service (SaaS) product is a platform for protein structure prediction via homology modeling, protein modeling, protein stabilization, protein engineering, and protein design for biologics and small molecules. In July 2018, Cyrus announced that it would release a new immune screening and prediction tool in the platform.

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture Investments, the W Fund, and more.